Sitemap
- Conclusive Evidence of Increased Avandia Osteoporosis Risk
- Study Finds Children With Diabetes More Likely To Develop Eating Disorder
- Avandia and Actos Pose Increased Bone Fracture Dangers to Women Suffering From Type 2 Diabetes
- GlaxoSmithKline Receives Avandia Warning from FDA
- Wall Street Journal Reports FDA and GlaxoSmithKline Did Not Follow Guidelines For Avandia
- Scientists Find a Link Between Osteoporosis and Depression
- Heart Failure Patients May Find Success With Cooling Treatment
- Researchers Find Heart Beats to Own Drum
- Scientists Have Discovered Two Cancer Drugs Capable of Reversing, Preventing Diabetes
- Gene Therapy Clinical Trial Gets Underway for Heart Failure Patients
- A Group of Doctors Petition FDA For Vegan Label on Avandia
- FDA Releases Warning of Avandia Heart Attack Risk
- News Outlets Continue to Report Avandia's Declining Sales, Status
- Avandia Makers Issue New Warning as Net Sales Plummet
- Possible Serious Side Effects Linked to Avandia
- Individuals With Depression at Risk for Developing Type 2 Diabetes
- Consumers Warned to Avoid Eating Raw Oysters from Southern Tip of Hood Canal in Washington State
- FDA Takes Action Against Iowa Dairy for Illegal Drug Residues Found in Cows
- FDA Warns Consumers to Avoid Red Yeast Rice Products Promoted on Internet as Treatments for High Cholesterol
- April 2007 Monthly Safety Labeling
- FDA Issues Safety Alert on Avandia
- March 2007 Monthly Safety Labeling Changes
- January 2007 Monthly Safety Labeling
- October 2006 Monthly Safety Labeling
- June 2006 Safety Labeling Changes
- Index to Drug-Specific Information
- Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information
- Information for Healthcare Professionals: Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl)
- Information for Healthcare Professionals: Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl)
- Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act
- Warning Letters and Untitled Letters to Pharmaceutical Companies 2007
- Warning Letters and Untitled Letters to Pharmaceutical Companies 2007
- Summaries of Medical and Clinical Pharmacology Reviews of Pediatric Studies
- New Drug Application (NDA) & Biologic License Application (BLA) Efficacy CY 2007
- CDER News Items 2007
- Paragraph IV Patent Certifications
- Tentative Approvals - December 2004
- Tentative Approvals - November 2005
- CDER NME Approvals in Calendar Year 1999
- Patient Information Sheet for Avandia
- Avandia - Glossary - A
- Avandia - Glossary - B
- Avandia - Glossary - C
- Avandia - Glossary - D
- Avandia - Glossary - E
- Avandia - Glossary - F
- Avandia - Glossary - G
- Avandia - Glossary - H
- Avandia - Glossary - I
- Avandia - Glossary - K
- Avandia - Glossary - L
- Avandia - Glossary - M
- Avandia - Glossary - N
- Avandia - Glossary - O
- Avandia - Glossary - P
- Avandia - Glossary - R
- Avandia - Glossary - S
- Avandia - Glossary - T
- Avandia - Glossary - U
- Medication Under a Microscope Studies Raise Questions About Drugs ...
- Business news in brief
- Medication Under a Microscope
- GlaxoSmithKline downgraded to 'A+/A-1' on financial policy concerns ...
- Diabetics' deaths tied to lower blood sugar
- Out of the Black Box: Marketing a Product with a Warning Box
- GSK bucks the trend as Buffett's buying boosts ailing drug giant
- Berkshire Hathaway buys $65m stake in GSK
- Nation’s prescription drug appetite waning
- GSK shelves growth plans, cuts jobs
- GSK shelves ambitious growth plans, cuts jobs
- SVG says pharmas help ease equity market pain
- 'Sensible' assumptions put public at risk
- Deaths Partially Halt Diabetes Study
- Experimental Diabetes Treatment
- Drugmaker sued over diabetes pill
- Oklahoma man alleges diabetes drug gave him heart problems.
- Florencia Halperin, M.D., Julie R. Ingelfinger, M.D., and Graham T ...
- Sanofi Posts Solid Results On Job Cuts, Plavix Sales
- Drugmaker sued over diabetes pill
- CME Author: Charles Vega, MD
- Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in ...
- Earnings Central Video On Demand
- FTSE closes at 5707.7
- UBS ups GlaxoSmithKline to "Buy" after sell-off last week; Credit ...
- UBS ups Glaxo shares on valuation
- FTSE falls on inflation concerns
- Diabetes study upends another long-held belief
- Deaths Halt Part of Large Diabetes Trial
- Zacks Bull and Bear of the Day Highlights: Omnivision, Corporate ...
- Diabetes study upends another long-held belief
- Deaths force NIH to halt diabetes tests
- UBS ups Glaxo shares on valuation
- Stock & fund quotes
- GSK foresees decline in profits
- AP: European stocks fall on poor earnings reports
- Outgoing GSK chief looks ahead to swing year
- CDS Report - Deutsche Bank tighter after Q4 surprises market
- European Stocks Drop on Growth Concern; Infineon, BT Group Fall
- European Stocks Drop on Growth Concern; Infineon, BT Group Fall
- European Stocks Drop on Growth Concern; Infineon, BT Group Fall
- Diabetics' deaths tied to lower blood sugar
- Upbeat brokers can't quite fix FTSE
- GSK Plunges on Further Avandia Woes
- GlaxoSmithKline responds to findings in ACCORD study
- ADRs in Focus: European pharmaceuticals
- New drug rules pose grave risks: critics
- FTSE ends higher as commodities lead
- European Stocks Drop; GlaxoSmithKline, Societe Generale Decline
- European Stocks Are Little Changed; GlaxoSmithKline Declines
- European Stocks Erase Gains; GlaxoSmithKline, TeliaSonera Fall
- Glaxosmithkline cut to 'AA-' on disappointing FY results, 2008 outlook ...
- Tentacles of sub-prime crisis tighten on UK firms
- Avandia problems hurt GSK profits
- GlaxoSmithKline's shares drop as profits fall
- Control deemed best for diabetics
- Glaxo chief curses media and issues profit warning
- Break-up not on agenda for Glaxo's new chief
- Glaxo's quarterly earnings drop 10%
- GSK Plunges on Further Avandia Woes
- Control deemed best for diabetics
- Glaxo Fourth-Quarter Profit Fell 10% on Avandia Sales (Update6)
- NHLBI Changes Intensive Blood Sugar Treatment Strategy In Clinical ...
- Deaths Stop Part Of Diabetes Trial
- Patients getting aggressive diabetes treatment have higher death risk
- FTSE shrugs off rate cut, down 2.6% on Glaxo, BT
- The Day After: Experts Puzzled Over Increased Death Rate in ACCORD
- UPDATE 3-Therapy not Avandia said to blame for trial deaths
- Drug Avandia proved to have no connection with increased number of ...
- NIH ends diabetes trial on deaths, says medications not responsible
- UPDATE 1-Avandia not to blame for deaths in trial, US says
- 2nd UPDATE:Avandia Not Linked To Increased Risk In Study -GSK
- RPT-Avandia not to blame for deaths in trial, US says
- Intensive-Glycemic-Control Arm of ACCORD Stopped
- Intensive blood sugar treatment in trial of diabetes and ...
- New Report Assesses How Changes in Diagnosis Rates Will Influence the ...
- Researcher Admits Leaking Diabetes Study
- Eisai/Pfizer's Aricept Owns a Dominating 42.4% Patient Share for First ...
- Unilever To Purchase Inmarko, Terms Not Disclosed [UL]
- GlaxoSmithKline's US Launch Of Cervarix In Doubt: FT [GSK]
- Journal reviewer tipped off drug firm before publication
- Need to know
- 'Fast Money' Recap: Financials Hurting
- No Quick Panaceas
- GSK’s US vaccine launch in doubt
- BP set to reveal fall in profits
- Web Special: Diabetes drug and conflicts of interest
- Web Exclusive: GEN's Annual Wall Street Roundup
- MORE STORIES
- Article on Avandia Study Was Leaked to Glaxo
- Drug data leaked to competitor
- Takeda and Daiichi profits up, Chugai shares tank
- Reviewer leaked data to Glaxo
- Latest News
- Lawsuit Online Signup over Avandia (Rosiglitazone) Side Effects is ...
- Latest News
- Latest News
- Latest News
- Latest News
- U.S. senator looks into leaked drug study
- More Avandia MSN Newsfeeds...
- Cardiosource
- Avandia (Rosiglitazone) and Heart Disease | A Sweet Life
- Avandia - Avandia side effects |LawyersandSettlements.com
- HLW Diabetic Health Warning: Do you take Avandia? | Cherry Hill
- The investigation of Mitogen-Activated Protein kinase Phosphatase-1 as apotential pharmacological target in non-small cell lung carcinomas,assisted by non-invasive molecular imaging - 7thSpace Interactive
- Odds Are, It's Wrong - Science News
- Medical News: Cardiology Groups Stand by Embattled Diabetes Drug - in Endocrinology, Diabetes from MedPage Today
- FDA reviewers probe health risks associated with diabetes drug Avandia | Press Release | JusticeNewsFlash Release
- Looking For Bad Guys
- PR-USA.net - An Attorney for You helping Patients Affected by New Potential Avandia Recall Lawsuits
- Diabetes market growing, obesity market shrinking: analysts - Biotechnology, diabetes, obesity, type 1 diabetes - Australian Life Scientist
- More FDA Corruption « oldfart
- Avandia Injury Suits Could Cost Drug Maker $6B: Report - AboutLawsuits.com
- The Associated Press: Senate report: Avandia maker knew of cardiac risks
- Drug companies versus safety | Letters | HoumaToday.com
- Rosiglitazone - A lifesaver or killer drug? - dnaindia.com
- South Asia Mail
- The IN VIVO Blog: Can a Biomarker Salvage Novartis' Joicela (AKA Prexige?)
- Market Report: Enterprise Inns raises a toast to MPs - Sharewatch, Business - The Independent
- Pharma cos filing multiple patents for same drug - dnaindia.com
- Cash sought for independent checks
- GSK faces up to $6B Avandia liability - FiercePharma
- A closer look at Avandia heart disease studies | A Sweet Life
- Cedars-Sinai Heart Institute Cardiologist Sanjay Kaul, M.D. Co-Authors Statement on Safety of Diabetes Drugs
- FRAUDULENT RESEARCH - Editorial
- The Associated Press: Glaxo defends handling of Avandia heart risks
- GSK Disputes Senate Report on Avandia, Claiming It Ignores Data, Meta-Analysis
- Avandia - Avandia side effects |LawyersandSettlements.com
- Nissen recorded 2007 meeting with GSK - FiercePharma
- InvestorPlace.com: Potential Avandia Lawsuits Threaten GlaxoSmithCline's (GSK) Bottom Line
- FDA: Avandia May Be Responsible For An Estimated 83,000 Heart Attacks
- NYT's Gardiner Harris Wears White and Black Hats - AGE OF AUTISM
- GlaxoSmithKline Slips on Avandia Controversy (GSK) | Comtex SmarTrend
- The Yeshiva World » Sunday Morning News Briefs from Eretz Yisrael » Frum Jewish News
- Avandia: Deemed Dangerous for Diabetics! | Gather
- Fact file: Avandia
- US-BUSINESS Summary - washingtonpost.com
- Avandia linked to 304 deaths, causes 500 heart... | Gather
- The FDA Follies And Death Drug Avandia – 24/7 Wall St.
- Is Avandia Linked to Heart Attacks? | Testing It Up – Drug & Health Testing News – Test Country Blog
- B?lore doctors play it safe
- Drug Improved Survival in Mice With Cystic Fibrosis - BusinessWeek
- Medical News | Health News - Defective Signaling Pathway Sheds Light on Cystic Fibrosis
- New Analysis Confirms Heart Failure Risk with Rosiglitazone | HealthandAge – Medical Articles and News for Health in Aging > Live Well, Live Longer
- C-reactive protein further reduced with TZDs | Resource Center: Type 2 Diabetes
- Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: in vivo and ex vivo studies - 7thSpace Interactive
- How Many Dads Have Died Due to Avandia? | InjuryBoard West Palm Beach
- Byetta and Avandia combined in the treatment of type 2 diabetes
- Study: Rosiglitazone use declined, pioglitazone use increased in recent years
- Share tips: 10 'best ideas' - Telegraph
- Diabetes medications may lead to increased risk of bone fracture in women
- Vildagliptin, un farmaco per il diabete di tipo 2
- Market Report -- In Play (WIRES): Briefing.com Business News - MSN Money
- The FDA's Black Box - Forbes.com
- Health Blog : Why Secrecy Still Shrouds FDA Drug Rejections
- Patients Sue Glaxo Claiming it Suppressed Data on Avandia
- A Practical "ABCDE" Approach to the Metabolic Syndrome - Health - redOrbit
- MinnPost - Federal whistleblowers need Coleman's help now
- Eastern Wake News | Glaxo planning more job cuts
- PR-CANADA.net - LegalView Offers Mesothelioma Blog Readers Details of Disconcerting Request to Decrease Asbestos Reg
- LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims
- Its About Your Community - Avandia Lawsuit Continues
- Bitter blow as 55 jobs axed at Montrose - Press & Journal
- PortageOnline.com - Its About Your Community - Avandia Lawsuit Continues
- Healthbeat: Diabetes in Kids
- Doctors Vary On List Of Drugs To Avoid - News Links Story - KMBC Kansas City
- Roger Drake: Attorney Believes More Avandia Cases To Come
- Avandia- the Drug that Keeps on Giving
- Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
- HAYS PHARMA
- Bloomberg.com: Asia
- Bloomberg.com: Asia
- GlaxoSmithKline earnings hurt by generics, Avandia - Triangle Business Journal:
- Glaxo CEO wants broader group, cautious on outlook
- Glaxo to invest in diversity, cautious on outlook | Reuters
- Avandia Study Shows 60 Percent Increase in Heart Failure Risk Among Diabetics who Take the Drug
- GlaxoSmithKline to lay off 90 in Zebulon - Triangle Business Journal:
- GlaxoSmithKline cuts 10% of Zebulon work force :: WRAL.com
- newsobserver.com | GSK in Zebulon fires 90 production workers
- GlaxoSmithKline to lay off 90 in Zebulon - Triangle Business Journal:
- GlaxoSmithKline cuts 10% of Zebulon work force :: WRAL.com
- newsobserver.com | GSK in Zebulon fires 90 production workers
- Therapeutics Daily
- Glaxo Changes Course
- GlaxoSmithKline cuts 10% of Zebulon work force :: WRAL.com
- newsobserver.com | GSK in Zebulon fires 90 production workers
- GlaxoSmithKline to lay off 90 in Zebulon - Triangle Business Journal:
- Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
- AFP: GlaxoSmithKline announces strategy overhaul after weak profits
- GlaxoSmithKline 2Q profit slips on competition - AP - National Business News - Portfolio.com
- Glaxo Earnings Fall 3 To 1 29bn (from The Herald )
- GlaxoSmithKline earnings hurt by generics, Avandia - Triangle Business Journal:
- Glaxo to invest in diversity, cautious on outlook - washingtonpost.com
- FT.com / Home UK / UK - Witty unveils three-fold approach for GSK
- GlaxoSmithKline 2Q profit slips on competition - AP - National Business News - Portfolio.com
- Glaxo Earnings Fall 3 To 1 29bn (from The Herald )
- GlaxoSmithKline earnings hurt by generics, Avandia - Triangle Business Journal:
- Glaxo to invest in diversity, cautious on outlook - washingtonpost.com
- FT.com / Home UK / UK - Witty unveils three-fold approach for GSK
- Diabetes Drug Avandia Causes Brittle Bones, Researchers Declare
- More Avandia News Articles...
- Thiazolidinedione
- Rosiglitazone
- Glimepiride
- Anti-diabetic drug
- GlaxoSmithKline
- Metformin
- Peroxisome proliferator-activated receptor
- Avandia concerns spark call for reforms; Drug-approval process endangers patients, experts say.(Health): An article from: Winnipeg Free Press
- Avandia hearing triggers finger-pointing.(News): An article from: Family Practice News
- Avandia problem reports triple; Published analysis likely alerted MDs.(Health): An article from: Winnipeg Free Press
- Avandia.: An article from: Family Practice News
- FDA gets brunt of criticism at House Avandia hearing.(Clinical Rounds)(Food and Drug Administration): An article from: Skin & Allergy News
- Keep Avandia on market: U.S. advisers.(World Wire): An article from: Winnipeg Free Press
- Lipodystrophy study: rosiglitazone. (Clinical Trial Information).(treatment research): An article from: HIV Treatment: ALERTS!
- New 'Glitazones' Appear Safer for Liver Than Rezulin.: An article from: Family Practice News
- No Liver Toxicity Problems With Avandia, Actos.(Brief Article): An article from: Family Practice News
- Woman sues drug company over vision loss; Diabetes medication blamed.(Health): An article from: Winnipeg Free Press
- Rosiglitazone - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Company defends heart safety of rosiglitazone.(News): An article from: Clinical Psychiatry News
- Comparison of metformin versus rosiglitazone in patients with acanthosis nigricans: a pilot study.: An article from: Journal of Drugs in Dermatology
- Euglycemia improves memory in type 2 diabetes: rosiglitazone, glyburide.(Clinical Rounds): An article from: Family Practice News
- High fracture rate found among women in rosiglitazone trials.(Metabolic Disorders): An article from: Family Practice News
- Method development and validation for the simultaneous determination of rosiglitazone and metformin in pharmaceutical preparations by capillary zone electrophoresis ... [An article from: Analytica Chimica Acta]
- Pioglitazone improved lipids better than rosiglitazone.(Metabolic Disorders): An article from: Family Practice News
- Rosiglitazone + amylose-free diet = weight loss. (HYPERINSULINEMIC OBESE PATIENTS).(Brief Article): An article from: Family Practice News
- Rosiglitazone associated with macular edema.(Rx) : An article from: Internal Medicine News
- Rosiglitazone cuts type 2 incidence in those at high risk: jury out on its use for disease prevention.(Clinical report): An article from: Family Practice News
- Rosiglitazone may elevate myocardial infarction risk.: An article from: Family Practice News
- Rosiglitazone reduces CRP, atherosclerosis in diabetics.(Cardiovascular Medicine)(C-reactive protein) : An article from: Internal Medicine News
- Rosiglitazone: at 10 years, no liver toxicity seen: experience in more than 7,000 patients shows the agent to be free of troglitazone's side effect.(Metabolic ... An article from: Family Practice News
- Rosiglitazone: no hepatotoxicity seen at 10 years.(Endocrinology): An article from: Internal Medicine News
- Spironolactone effectively counteracts rosiglitazone-associated edema.(Metabolic Disorders) : An article from: Family Practice News
- Spironolactone reduces edema from rosiglitazone.(Endocrinology): An article from: Internal Medicine News
- Diabetes drug exposure may protect against SCC: thiazolidinediones significantly lowered the risk for cancers of the head and neck, including the larynx.(Clinical ... An article from: Skin & Allergy News
- Experts discuss options for rosiglitazone use.(Metabolic Disorders )(American Diabetes Association): An article from: Family Practice News
- More reports of health problems linked to Avandia.(Health): An article from: Winnipeg Free Press
- Virden man tries to launch class action.(City): An article from: Winnipeg Free Press
- Debate renewed: diabetes drug ups heart risk.(This Week)(rosiglitazone): An article from: Science News
- Rosiglitazone can stay on the market, despite heart risk: FDA staff is divided over the decision.(News)(Food and Drug Administration): An article from: Family Practice News
- Thiazolidinediones receive black box for heart failure: careful monitoring of patients advised.(News): An article from: Family Practice News
- Celebrity Chefs Across America Ingredients for Managing Diabetes ((AADE) American Association of Diabetes Educators)
- Celebrity Chefs Across America..the Ingredients for Managing Diabetes
- Celebrity Chefs Across American...the Ingredients for Manageing Diabetes
- Consider alternatives to controversial drug: if you're concerned about using rosiglitazone for your diabetes, a leading heart expert recommends talking ... An article from: Men's Health Advisor
- Rosiglitazone cut incidence of type 2 diabetes.(Endocrinology): An article from: Internal Medicine News
- Rosiglitazone has lower treatment failure rate.(Endocrinology): An article from: Internal Medicine News
- Physicians notified of elevated fracture rate in rosiglitazone-treated women.(News): An article from: Internal Medicine News
- Myocardial infarction warning added to Avandia's black box.(News): An article from: Family Practice News
- Celebrity Chefs Across America
- Spironolactone effectively counteracts rosiglitazone-associated edema.(Metabolic Disorders): An article from: Family Practice News
- Rosiglitazone tied to macular edema, FDA warns.(Metabolic Disorders)(Food and Drug Administration): An article from: Family Practice News
- Rosiglitazone reduces CRP, atherosclerosis in diabetics.(Cardiovascular Medicine)(C-reactive protein): An article from: Internal Medicine News
- Rosiglitazone associated with macular edema.(Rx): An article from: Internal Medicine News
- Guidance on rosiglitazone for type 2 diabetes mellitus: Information for patients
- FDA panel favors keeping c on market.(News)(Food and Drug Administration): An article from: Internal Medicine News
- Rosiglitazone performs poorly in meta-analysis.(Endocrinology): An article from: Internal Medicine News
- Celebrity Chefs Across America.the Ingredients for Managing Diabetes
- Avandia, other drugs are bitter pills for diabetics, suits say.: An article from: Trial
- FDA's Role in the Evaluation of Avandia's Safety: Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundr
- Diabetes raises dementia risk, but drugs may lower it: diabetes can cause vascular dementia, but medications may help prevent this complication.(RISK REDUCTION): ... An article from: Women's Health Advisor
- Drug Muggers - How To Keep Your Medicine From Stealing The Life Out Of You.
- Celebrity Chefs Across America: The Ingredients for Managing Diabetes
- Mortality found no higher with rosiglitazone.(METABOLIC DISORDERS)(Clinical report): An article from: Family Practice News
- Record: mortality no higher with rosiglitazone.(NEWS)(Report): An article from: Internal Medicine News
- Rosiglitazone risks outpace pioglitazone's in the elderly.(Metabolic Disorders): An article from: Family Practice News
- Avandia Recall
- Avandia Settlement
- Avandia
- About Avandia
- Avandia Lawyers and Lawsuits
- Do You Have an Avandia Case?
- Do You Need an Avandia Lawyer?
- Avandia Background
- What Is Avandia?
- Uses For Avandia
- Side Effects of Avandia
- FDA Concerns and Warnings About Avandia
- Avandia FAQ
- Detailed Info on Avandia
- Avandia Clinical Trials
- Heart Problems and Avandia
- Osteoperosis and Avandia
- Legal Assistance for Avandia Victims
- Find an Avandia Law Firm
- Avandia Lawsuit Results and Verdicts
- Do You Need an Avandia Attorney?
- Avandia Wrongful Death Information
- Filing Your Avandia Lawsuit - Frequently Asked Questions
- About Legalview's Lawfirms
- Thank You For Your Submission
- Disclaimer
- Contact Us






